Evidence Suggests CBD Potential in Treating COVID-19

Since the start of the ongoing outbreak, the cannabis industry has been the source of some debate as stakeholders and active consumers attempt to understand COVID-19’s far-reaching effects. Pulmonologists and lung experts have cautioned that inhaled smoke from combusted plant material – be it … Read more about Evidence Suggests CBD Potential in Treating COVID-19

Amendment to NDAA Would Allow Military Service Members to Use CBD Products

A recently passed amendment to the National Defense Authorization Act (“NDAA”) could allow military service members to use cannabidiol (“CBD”) and other hemp-derived products. The measure, sponsored by veteran Rep. Tulsi Gabbard (D-HI), was introduced on July 20, 2020, and was passed in the House of … Read more about Amendment to NDAA Would Allow Military Service Members to Use CBD Products

DEA Removes CBD from Controlled Substances Act

On Monday, April 6, GW Pharmaceuticals revealed that the company had received notice from the U.S. Drug Enforcement Administration (“DEA”) stating that its drug Epidiolex was no longer subject to the requirements of the Controlled Substances Act (“CSA”). In a company release announcing the agency … Read more about DEA Removes CBD from Controlled Substances Act

FDA Recognizes the Need for CBD Regulation

On February 26, 2020 the Food and Drug Administration’s (“FDA”) new commissioner, Dr. Stephen Hahn, acknowledged the growing consumer demand for CBD products. “People are using these [CBD] products,” Hahn said in his first public speech regarding CBD since taking office in December. “We are not … Read more about FDA Recognizes the Need for CBD Regulation

New Bill Proposes Solution to CBD Regulation

On January 13, 2020, the chairman of the U.S. House Committee on Agriculture, Representative Collin Peterson (D-MN), introduced a bill to address one of the largest issues in the burgeoning hemp industry – the regulation of cannabidiol (“CBD”). H.R.5587 aims to amend existing legislation to grant … Read more about New Bill Proposes Solution to CBD Regulation

Westword Publishes Managing Partner’s Article on CBD & Schedule I

Nearly a year after the passing of the Agriculture Improvement Act of 2018 (“2018 Farm Bill”), the industrial hemp and cannabidiol (“CBD”) markets are booming, yet ingestible products are still illegal according to the federal government. With mounting pressure on the U.S. Food and Drug … Read more about Westword Publishes Managing Partner’s Article on CBD & Schedule I

Recent FTC Warning Letters Target CBD Medical Claims

September 10, 2019, the U.S. Federal Trade Commission (“FTC”) issued a news release announcing the recent distribution of warning letters to three companies advertising cannabidiol (“CBD”) products as a medical treatment option for a range of various illnesses. Cautioning that such unsubstantiated … Read more about Recent FTC Warning Letters Target CBD Medical Claims

Proposed California CBD Bill Suspended

Contrary to the bill’s projected outcome from earlier in the summer, California lawmakers will not make a decision on Assembly Bill-228 (“AB 228”) this year as the bill has stalled in the state legislature despite broad bipartisan interest and consumer support. Previously expected to be signed into … Read more about Proposed California CBD Bill Suspended